Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
Luca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International
|
December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour
Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
World Journal of Urology
|
March 13, 2022
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility
Christian D Fankhauser, Luca Afferi, Sean P Stroup, et al.
Immunity
|
April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Frederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Cancer Discovery
|
January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Cell
|
March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Cancer Discovery
|
January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Nature Ecology & Evolution
|
December 24, 2021
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
Xiao Fu, Yue Zhao, Jose I Lopez, et al.
Genome Biology
|
August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
Rosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Cell
|
April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer
Luca Antonelli, Davide Ardizzone, Isamu Tachibana, et al.
BJU International
|
December 11, 2024
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour
Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, et al.
World Journal of Urology
|
March 13, 2022
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility
Christian D Fankhauser, Luca Afferi, Sean P Stroup, et al.
Immunity
|
April 16, 2017
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Frederick Arce Vargas, Andrew J S Furness, Isabelle Solomon, et al.
Cancer Discovery
|
January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx Renal
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Cell
|
March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
Cancer Discovery
|
January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal
Ángel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Nature Ecology & Evolution
|
December 24, 2021
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
Xiao Fu, Yue Zhao, Jose I Lopez, et al.
Genome Biology
|
August 28, 2014
Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution
Rosalie Fisher, Stuart Horswell, Andrew Rowan, et al.
Cell
|
April 17, 2018
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J Mitchell, Samra Turajlic, Andrew Rowan, et al.
Page
of 9